Literature DB >> 15793001

Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.

Danijela Koppers-Lalic1, Eric A J Reits, Maaike E Ressing, Andrea D Lipinska, Rupert Abele, Joachim Koch, Marisa Marcondes Rezende, Pieter Admiraal, Daphne van Leeuwen, Krystyna Bienkowska-Szewczyk, Thomas C Mettenleiter, Frans A M Rijsewijk, Robert Tampé, Jacques Neefjes, Emmanuel J H J Wiertz.   

Abstract

Detection and elimination of virus-infected cells by cytotoxic T lymphocytes depends on recognition of virus-derived peptides presented by MHC class I molecules. A critical step in this process is the translocation of peptides from the cytoplasm into the endoplasmic reticulum by the transporter associated with antigen processing (TAP). Here, we identified the bovine herpesvirus 1-encoded UL49.5 protein as a potent inhibitor of TAP. The expression of UL49.5 results in down-regulation of MHC class I molecules at the cell surface and inhibits detection and lysis of the cells by cytotoxic T lymphocytes. UL49.5 homologs encoded by two other varicelloviruses, pseudorabies-virus and equine herpesvirus 1, also block TAP. Homologs of UL49.5 are widely present in herpesviruses, acting as interaction partners for glycoprotein M, but in several varicelloviruses UL49.5 has uniquely evolved additional functions that mediate its participation in TAP inhibition. Inactivation of TAP by UL49.5 involves two events: inhibition of peptide transport through a conformational arrest of the transporter and degradation of TAP by proteasomes. UL49.5 is degraded along with TAP via a reaction that requires the cytoplasmic tail of UL49.5. Thus, UL49.5 represents a unique immune evasion protein that inactivates TAP through a unique two-tiered process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793001      PMCID: PMC555605          DOI: 10.1073/pnas.0501463102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Viral subversion of the immune system.

Authors:  D Tortorella; B E Gewurz; M H Furman; D J Schust; H L Ploegh
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Intracellular surveillance: controlling the assembly of MHC class I-peptide complexes.

Authors:  P Cresswell
Journal:  Traffic       Date:  2000-04       Impact factor: 6.215

3.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression.

Authors:  E M Bennett; J R Bennink; J W Yewdell; F M Brodsky
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

4.  Powering the peptide pump: TAP crosstalk with energetic nucleotides.

Authors:  Peter M van Endert; Loredana Saveanu; Eric W Hewitt; Paul Lehner
Journal:  Trends Biochem Sci       Date:  2002-09       Impact factor: 13.807

5.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.

Authors:  E W Hewitt; S S Gupta; P J Lehner
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

6.  Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens.

Authors:  J I Cohen
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

7.  The major substrates for TAP in vivo are derived from newly synthesized proteins.

Authors:  E A Reits; J C Vos; M Grommé; J Neefjes
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

8.  Equine herpesvirus 1 (EHV-1) glycoprotein M: effect of deletions of transmembrane domains.

Authors:  C Seyboldt; H Granzow; N Osterrieder
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

9.  An early pseudorabies virus protein down-regulates porcine MHC class I expression by inhibition of transporter associated with antigen processing (TAP).

Authors:  A P Ambagala; S Hinkley; S Srikumaran
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

10.  Bovine herpesvirus 1 glycoprotein M forms a disulfide-linked heterodimer with the U(L)49.5 protein.

Authors:  S X Wu; X P Zhu; G J Letchworth
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more
  62 in total

1.  Epstein-Barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP.

Authors:  Agnes I Wycisk; Jiacheng Lin; Sandra Loch; Kathleen Hobohm; Jessica Funke; Ralph Wieneke; Joachim Koch; William R Skach; Peter U Mayerhofer; Robert Tampé
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

Review 2.  ABC proteins in antigen translocation and viral inhibition.

Authors:  David Parcej; Robert Tampé
Journal:  Nat Chem Biol       Date:  2010-08       Impact factor: 15.040

3.  Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I.

Authors:  Guanggang Ma; Silke Feineis; Nikolaus Osterrieder; Gerlinde R Van de Walle
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 4.  Viral evasion of the MHC class I antigen-processing machinery.

Authors:  Sandra Loch; Robert Tampé
Journal:  Pflugers Arch       Date:  2005-08-06       Impact factor: 3.657

Review 5.  Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.

Authors:  Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

Review 6.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

7.  Bovine herpesvirus 1 productive infection stimulates inflammasome formation and caspase 1 activity.

Authors:  Jianlin Wang; Jeff Alexander; Matthew Wiebe; Clinton Jones
Journal:  Virus Res       Date:  2014-03-20       Impact factor: 3.303

Review 8.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

9.  CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

Authors:  Ania Skowera; Richard J Ellis; Ruben Varela-Calviño; Sefina Arif; Guo Cai Huang; Cassie Van-Krinks; Anna Zaremba; Chloe Rackham; Jennifer S Allen; Timothy I M Tree; Min Zhao; Colin M Dayan; Andrew K Sewell; Wendy W Unger; Wendy Unger; Jan W Drijfhout; Ferry Ossendorp; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 10.  Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity.

Authors:  Martin Rowe; Jianmin Zuo
Journal:  Microbes Infect       Date:  2010-02-01       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.